Skip to main content
. Author manuscript; available in PMC: 2009 Dec 3.
Published in final edited form as: Anticancer Res. 2008 Jul–Aug;28(4B):2027–2031.

Figure 4.

Figure 4

Tumor growth delay of Caki-1 tumors treated with Avastin and/or OXi4503. The treatment schedule is described in Figure 2; however, the dose of OX14503 was 10 mg/kg. The data shown are the median, 75th and 90th percentiles of responses of tumors treated at a starting size of 200 mm3.